The Chorionic Gonadotropin Shortage in 2026: Where Things Stand

If you depend on Chorionic Gonadotropin — whether for fertility treatment, testosterone therapy, or another medical condition — you've likely felt the impact of the ongoing supply problems. The HCG shortage has been a reality for patients since 2020, and while the situation has evolved, it hasn't fully resolved.

This article gives you a clear, up-to-date picture of where things stand in 2026: what's causing the shortage, how much the medication costs right now, what new options are available, and how to actually find Chorionic Gonadotropin in stock.

Is Chorionic Gonadotropin Still in Shortage?

Yes, as of early 2026, Chorionic Gonadotropin remains in intermittent shortage. The drug is listed on the American Society of Health-System Pharmacists (ASHP) drug shortage database, and availability varies by region, pharmacy type, and specific product.

Here's what that means in practice:

• Some pharmacies have it in stock; others don't
• Brand-name products (Pregnyl, Novarel) may be available at one pharmacy but backordered at another
• Generic versions may have slightly better availability in some areas
• Supply can fluctuate week to week

The shortage is not a complete absence of the drug — it's an unpredictable, location-dependent supply problem that makes it harder to find than most medications.

Why Is Chorionic Gonadotropin Hard to Find?

The shortage has multiple causes that have compounded over time. Understanding them can help you plan ahead.

The 2020 Biologic Reclassification

The single biggest factor was the FDA's reclassification of HCG as a biologic product on March 23, 2020, under the Biologics Price Competition and Innovation Act (BPCIA). Before this change, compounding pharmacies produced a large share of the HCG supply — especially for men's health clinics and TRT patients.

Once HCG became a biologic, compounding pharmacies needed a special license that most didn't have. Virtually overnight, a significant portion of the U.S. supply disappeared.

FDA Enforcement Actions (2022–2023)

In the years following the reclassification, the FDA cracked down on compounding pharmacies that continued to produce HCG without proper authorization. This further reduced supply and pushed more patients toward the limited number of FDA-approved products.

Limited Manufacturers

Only a handful of companies produce FDA-approved Chorionic Gonadotropin:

• Organon — manufactures Pregnyl
• Ferring Pharmaceuticals — manufactures Novarel
• EMD Serono — manufactures Ovidrel (recombinant version)
• A small number of generic manufacturers

With so few producers, any manufacturing delay or quality issue at even one facility can ripple through the entire supply chain.

Surging Demand

Demand for HCG has grown significantly. Fertility treatments are more common than ever, testosterone replacement therapy has expanded dramatically, and awareness of HCG's role in preserving fertility during TRT has increased. More patients need the same limited supply.

How Much Does Chorionic Gonadotropin Cost in 2026?

Cost is a major concern, especially for patients paying out of pocket. Here's what you can expect:

• Generic Chorionic Gonadotropin: $80–$200 per 10,000-unit vial
• Pregnyl (brand): $100–$250 per 10,000-unit vial
• Novarel (brand): $100–$250 per 10,000-unit vial
• Ovidrel (recombinant): $200–$400+ per prefilled syringe

Without insurance, the average retail price for a 10,000-unit vial is around $465, though discount cards can bring it down to the $150–$300 range. For details on saving money, see our guide on how to save money on Chorionic Gonadotropin in 2026.

Insurance Coverage

Coverage varies widely:

• Many plans cover HCG for FDA-approved indications like cryptorchidism and hypogonadism
• Fertility-related uses often require prior authorization
• Some states mandate fertility treatment coverage, which may include HCG
• Step therapy requirements may apply — meaning your insurer wants you to try other options first

If you're unsure about your coverage, call the number on the back of your insurance card and ask specifically about Chorionic Gonadotropin injection coverage.

Are There New Options in 2026?

While no major new HCG products have launched recently, there are a few developments worth knowing about:

Recombinant HCG (Ovidrel)

Ovidrel continues to be the main alternative for fertility patients. Because it's manufactured using recombinant DNA technology rather than urine extraction, its supply is somewhat more predictable. If you can't find urinary-derived HCG, ask your doctor about switching.

Lupron Trigger Protocols

More IVF clinics are incorporating Lupron trigger shots into their protocols, reducing the need for HCG in some patients. This approach also lowers the risk of ovarian hyperstimulation syndrome. Learn more in our article on alternatives to Chorionic Gonadotropin.

Oral Alternatives for Men

For men who were using HCG as part of TRT, medications like Clomiphene Citrate (Clomid) and Enclomiphene are being used off-label to stimulate natural testosterone production and preserve fertility. These oral options bypass the HCG supply problem entirely, though they work through a different mechanism.

How to Find Chorionic Gonadotropin in Stock

Here are the most effective strategies for locating the medication:

1. Use Medfinder to check real-time pharmacy stock near your ZIP code
2. Contact specialty pharmacies that serve fertility clinics — they often maintain dedicated HCG supply
3. Ask your prescriber for pharmacy referrals — they know which pharmacies keep HCG on hand
4. Call pharmacies early in the week when new shipments typically arrive (Monday–Tuesday)
5. Order in advance — if you know your treatment timeline, ask your pharmacy to reserve supply 1–2 weeks ahead

For a deeper dive, read our full guide on how to find Chorionic Gonadotropin in stock near you.

Final Thoughts

The Chorionic Gonadotropin shortage in 2026 is an ongoing challenge, but it's not a dead end. The medication is still being manufactured, alternatives exist, and tools like Medfinder make the search much more manageable.

Stay proactive, work with your healthcare team, and don't hesitate to explore alternatives if your usual product is unavailable. The supply situation is expected to gradually improve as manufacturers adjust to post-reclassification demand, but in the meantime, planning ahead is your best defense.

If you're experiencing side effects from Chorionic Gonadotropin or a new alternative, check out our article on Chorionic Gonadotropin side effects: what to expect and when to call your doctor.